Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1

Conditions

Lung Neoplasms 2Testicular Neoplasms 1Pleural Diseases 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Mesothelioma 1Liver Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Etoposide 19Carboplatin 19Ifosfamide 16Filgrastim 16Peripheral Blood Stem Cell Transplantation 13Paclitaxel 13Cisplatin 12Cyclophosphamide 10Thiotepa 7Therapeutics 5Radiotherapy 5Melphalan 5Busulfan 5Magnetic Resonance Spectroscopy 4Gemcitabine 4Flow Cytometry 4pegfilgrastim 3etoposide phosphate 3Surveys and Questionnaires 3Psychiatric Rehabilitation 3Methylprednisolone 3Methods 3Immunologic Techniques 3Granulocyte Colony-Stimulating Factor 3Epirubicin 3Dexamethasone 3Blood Specimen Collection 3Bleomycin 3tremelimumab 2durvalumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Testicular Neoplasms × Mesothelin × Clear all
NCT05410717 2024-06-25

CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors

Second Affiliated Hospital of Guangzhou Medical University

Phase 1 Recruiting
200 enrolled
GenitourinaryGynecologic

Ovarian Neoplasms, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡